QCRH QCR
QCR earnings company data as of 4:47 AM ET 10/2
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 28 Oct | EPS | 2.09 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by QCRH's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $14K bought by 1 insider
- $918K sold by 3 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Amy L Reasner DirectorBuy$5,415 60 shares at $90.25 +4.3% to stakeTraded Jun 2 Filed Jun 10
-
Laura L Ekizian President & CEO, QCBTSale$71K 750 shares at $94.96 11% of stakeTraded Jun 9 Filed Jun 10
-
James D. Klein President, CRBTSale$26K 428 shares at $60.74 58% of stakeTraded May 12, 2025 Filed Jun 8
-
James D. Klein President, CRBTSale$28K 310 shares at $91.00 42% of stakeTraded Apr 30 Filed Apr 30
-
Amy L Reasner DirectorBuy$8,835 100 shares at $88.35 +7.6% to stakeTraded Apr 23 Filed Apr 24
-
James D. Klein President, CRBTSale$46K 554 shares at $82.50 43% of stakeTraded Mar 12 Filed Mar 12
-
Todd A Gipple CFOSale$772K 8,590 shares at $89.92 16% of stakeTraded Jan 30 Filed Feb 2
Also filed in the last 12 months, not counted as buying or selling: 30 option exercises and 10 stock grants.
SEC filings
Recent issuer filings from EDGAR, 14 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 5.07,8.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| DEF 14A | FORM DEF 14A | Filing Doc | |
| DEFA14A | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.